NEW YORK--(BUSINESS WIRE)--April 18, 2006--Bodisen Biotech, Inc.,
(AMEX:BBC, London AIM:BODI, website: /), the
first China based environmentally friendly bio fertilizer company
listed on a US stock exchange, and dually listed in London,
announced today that the Company's President Mr. Bo Chen received an
"Outstanding Manager" award for exceptional performance from the
local government. The award recognizes excellence in managerial
capabilities and contribution to the local economy.
Bodisen expects to report record first quarter financial results
(ended March 31, 2006) before May 15, 2006.
Karen Qiong Wang, Chairman and CEO of Bodisen commented: "Bodisen
congratulates Mr. Chen for his achievement and the Company
appreciates his continued leadership as Bodisen's President and the
founder of Bodisen. As a well known agricultural scientist who
invented Bodisen's unique organic fertilizer manufacturing process,
Mr. Chen has been instrumental in managing the daily operations of
the Company and executing on our growth plan since the Company's
Mr. Bo Chen, President of Bodisen commented: "During the first
quarter, Bodisen experienced strong customer demand. As a result,
the Company substantially increased its total staff to approximately
900. Product sales during the 2nd quarter are well on target.
Bodisen's management appreciates our dedicated staff and our
shareholders for their support."
Bodisen has two production facilities located approximately half
a mile apart. The local government has recently started building a
new road in front of the main entrance to the company's older
facility under the city's new urban planning initiatives. Although
the inconvenience has lasted over a month and may continue for
several months at the front entrance, construction is not expected
to affect the company's product inventory and shipment operations
which are processed at the facility's back entrance and the company
reaffirmed its 2006 sales and earnings guidance.
Bodisen's Chairman and CEO Karen Qiong Wang is taking temporary
sick leave for a periodic follow up medical check up as a result of
a surgery performed at the end of last year. The Company does not
expect interruption of its business operations during her short
absence. Mr. Bo Chen will continue to lead the Company during Ms.
Wang's medical check up.
Bodisen has recently updated its official website:
www.bodisen.com . The Company does not recognize any other websites
allegedly belonging to Bodisen or its subsidiary companies.
About Bodisen Biotech, Inc.
A Delaware company, Bodisen is headquartered in Shaanxi, China's
agricultural hub. In January 2006, Bodisen was ranked the 16th
fastest growing company in China by Forbes China. The Bodisen brand
is a highly recognized fertilizer brand in China. Its
environmentally friendly "green" products support the mandate of the
Chinese government to increase crop yields for the purpose of
decreasing China's dependency on food imports. Utilizing proprietary
agricultural technologies, Bodisen sells over 60 packaged products,
broken down into 4 product categories: Organic Compound Fertilizer;
Organic Liquid Fertilizer; Pesticides & Insecticides, and
agricultural raw materials. Bodisen's organic fertilizers are
government certified as "organic" and can be absorbed by plants
within 48 hours and enrich soil conditions without the damaging
effects associated with chemical fertilizers. Bodisen's products
address grains, vegetables, and fruit crops and have been proven to
increase crop yields by 10% to 35% while being environmentally
friendly. Among China's population of 1.3 billion, approximately 900
million are farmers or have agriculture related jobs whose incomes
depend on their crop yields. With approximately 600 (and growing)
nationwide distribution centers, Bodisen has experienced rapid
Safe Harbor Statement
This press release may contain forward-looking statements within
the meaning of the "safe harbor" provisions of the Private
Securities Litigation Reform Act of 1995. These statements are based
on the current expectations or beliefs of Bodisen Biotech, Inc.
management and are subject to a number of factors and uncertainties
that could cause actual results to differ materially from those
described in the forward-looking statements.